Prevalence of periodontitis and systemic inflammation assessed by C reactive protein in Sudanese hemodialysis patients with end stage renal disease
Keywords:
Periodontitis, end-stage renal disease, C-reactive protein, hemodialysis, Sudan, systemic inflammationAbstract
Background: A potential bidirectional link between periodontitis and systemic diseases, including end-stage renal disease (ESRD), has long been speculated. Elevated systemic inflammation in ESRD patients may be exacerbated by chronic periodontal infection. This study aimed to assess the prevalence of periodontitis and its association with systemic inflammation, measured by serum C-reactive protein (CRP), in Sudanese patients receiving hemodialysis.
Methods: A multicenter, hospital-based, analytic cross-sectional study was conducted at six dialysis centers in Khartoum. One hundred ESRD patients aged 25–45 years, on maintenance hemodialysis, were recruited. Periodontal examination included plaque index (PI), bleeding on probing (BOP) , probing pocket depth (PPD), and clinical attachment loss (CAL). Serum CRP levels were measured using immunofluorescent assay (cutoff >10 mg/L).
Results: The prevalence of periodontitis was 83%, with moderate cases being most common (47%). Mean CRP level in periodontitis patients was 7.89 ± 7.92 mg/L. No statistically significant association was found between periodontitis and elevated CRP (P = 0.99), nor between CRP and periodontal parameters (PI, BOP, PPD, CAL). However, CAL was significantly associated with gender (P = 0.036), and it showed a marginal association with dialysis duration (P = 0.242).
Conclusion: Periodontitis is highly prevalent among ESRD patients on hemodialysis in Sudan, yet it was not found to be associated with elevated systemic inflammation as measured by CRP. Further studies with larger sample sizes and additional biomarkers are warranted to explore this relationship more deeply.
References
1. López-Sanz L, León-López M, Egido-Moreno S, et al. Chronic kidney disease and chronic oral inflammatory diseases: a systematic review and meta-analysis of periodontitis and apical periodontitis. J Clin Med 2024;14(22):7947. doi:10.3390/jcm14227947.
2. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 2022;12(1):7. doi:10.1016/j.kisu.2021.11.003.
3. GBD 2023 Chronic Kidney Disease Collaborators. Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 2025. doi:10.1016/S0140-6736(25)01853-7.
4. Kalyesubula R, Aklilu AM, Calice-Silva V, Kumar V, Kansiime G. The future of kidney care in low- and middle-income countries: challenges, triumphs, and opportunities. Kidney360 2024;5(7):1047-61. doi:10.34067/KID.0000000000000489.
5. Younis RA, Omar SM, Alotaibi EA, Adam I. Prevalence and factors associated with chronic kidney disease in Gezira, Central Sudan: a community-based cross-sectional study. BMC Nephrol 2025;26:630. doi:10.1186/s12882-025-04571-9.
6. Wu Q, Zhang W, Lu Y, et al. Association between periodontitis and inflammatory comorbidities: the common role of innate immune cells, underlying mechanisms and therapeutic targets. Int Immunopharmacol 2024;128:111558. doi:10.1016/j.intimp.2024.111558.
7. Petersen PE, Ogawa H. The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontol 2000 2012;60:15-39. doi:10.1111/j.1600-0757.2012.00495.x.
8. Hashim NT, Babiker R, Padmanabhan V, et al. The global burden of periodontal disease: a narrative review on unveiling socioeconomic and health challenges. Int J Environ Res Public Health 2025;22(4):624. doi:10.3390/ijerph22040624.
9. Lamloum D, Campus G. A descriptive review of the healthcare system and the provision of oral healthcare in the Republic of Sudan. Int Dent J 2024;74(5):930. doi:10.1016/j.identj.2024.05.012.
10. Pengpid S, Peltzer K. Prevalence and correlates of dental service utilisation among national adult population in Sudan. BMC Oral Health 2021;21:61. doi:10.1186/s12903-021-01422-5.
11. Al-Harthi LS, Cullinan MP, Leichter JW, Thomson WM. Periodontitis among adult populations in the Arab world. Int Dent J 2020;63(1):7. doi:10.1111/idj.12002.
12. Elamin AM, Skaug N, Ali RW, Bakken V, Albandar JM. Ethnic disparities in prevalence of periodontitis among high school students in Sudan. J Periodontol 2010;81(6):891-6. doi:10.1902/jop.2010.090709.
13. Baciu SF, Mesaros S, Kacso IM. Chronic kidney disease and periodontitis interplay: a narrative review. Int J Environ Res Public Health 2023;20(2):1298. doi:10.3390/ijerph20021298.
14. Martínez-García M, Hernández-Lemus E. Pro-inflammatory and anti-inflammatory interleukins in periodontitis: molecular roles, immune crosstalk, and therapeutic perspectives. Int J Mol Sci 2025;26(20):10094. doi:10.3390/ijms262010094.
15. Li S, Cao H, Zhang Y, et al. Periodontal disease and chronic kidney disease: mechanistic insights and novel therapeutic perspectives. Front Cell Infect Microbiol 2025;15:1611097. doi:10.3389/fcimb.2025.1611097.
16. Zhou H, Tang Y, Xu T, Cheng B. C-reactive protein: structure, function, regulation, and role in clinical diseases. Front Immunol 2024;15:1425168. doi:10.3389/fimmu.2024.1425168.
17. Kunin M, Mini S, Abu-Amer N, Beckerman P. Acute asymptomatic C-reactive protein rise predicts adverse events in peritoneal dialysis patients. Am J Med Sci 2025;370(6):529-34. doi:10.1016/j.amjms.2025.08.001.
18. Bansal T, Pandey A, Asthana AK. C-reactive protein and its association with periodontal disease: a brief review. J Clin Diagn Res 2014;8(7):ZE21. doi:10.7860/JCDR/2014/8355.4646.
19. Alhammali W, Jbireal M. Serum biomarkers and periodontal disease in Libyan hemodialysis patients. Khalij-Libya J Dent Med Res 2025;243-50. doi:10.47705/kjdmr.259216.
20. Silness J, Löe H. Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22(1):121-35. doi:10.3109/00016356408993968.
21. Caton JG, Armitage G, Berglundh T, et al. A new classification scheme for periodontal and peri-implant diseases and conditions: introduction and key changes from the 1999 classification. J Periodontol 2018;89(S1): S1-8. doi:10.1002/JPER.18-0157.
22. Thorman R, Neovius M, Hylander B. Clinical findings in oral health during progression of CKD to ESRD in Swedish patients. Scand J Urol Nephrol 2009;43:154-9. doi:10.1080/00365590802464817.
23. Kim YJ, Moura LM, Caldas CP, Perozini C, Ruivo GF, Pallos D. Evaluation of periodontal condition and risk in hemodialysis patients. Einstein (Sao Paulo) 2017;15:173-7. doi:10.1590/S1679-45082017AO3867.
24. Altamimi AG, AlBakr SA, Alanazi TA, Alshahrani FA, Chalisserry EP, Anil S. Prevalence of periodontitis in hemodialysis patients: a case–control study. Mater Sociomed 2018;30(1):58-61. doi:10.5455/msm.2018.30.58-61.
25. Rani AN, Reddy MP, Kulkarni S, Srilatha A, Reddy LS. Assessment of periodontal status in renal dialysis patients. J Indian Soc Periodontol 2024;28(2):224. doi:10.4103/jisp.jisp_335_23.
26. Cohen G. Immune dysfunction in uremia. Toxins (Basel) 2020;12(7):439. doi:10.3390/toxins12070439.
27. Schulze A, Busse M. Gender differences in periodontal status and oral hygiene of non-diabetic and type 2 diabetic patients. Open Dent J 2016;10:287. doi:10.2174/1874210601610010287.
28. Rajeh MT. Gender differences in oral health knowledge and practices among adults in Jeddah, Saudi Arabia. Clin Cosmet Investig Dent 2022;14:235. doi:10.2147/CCIDE.S379171.
29. Shiau HJ, Reynolds MA. Sex differences in destructive periodontal disease: a systematic review. J Periodontol 2010;81(10):1379-89. doi:10.1902/jop.2010.100044.
30. Wahaidi V, Dowsett S, Eckert G, Kowolik M. Neutrophil response to dental plaque by gender and race. J Dent Res 2009;88(8):709. doi:10.1177/0022034509339019.
31. Lipsky MS, Su S, Crespo CJ, Hung M. Men and oral health: a review of sex and gender differences. Am J Mens Health 2021;15(3):15579883211016361. doi:10.1177/15579883211016361.
32. Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and oxidative stress in CKD—therapeutic role of minerals, vitamins and plant-derived metabolites. Int J Mol Sci 2019;21(1):263. doi:10.3390/ijms21010263.
33. Cholewa M, Madziarska K, Radwan-Oczko M. Association between periodontal conditions, inflammation, nutritional status and calcium-phosphate disorders in hemodialysis patients. J Appl Oral Sci 2018;26:e20170495. doi:10.1590/1678-7757-2017-0495.
34. Ghanem AS. The role of systemic health indicators, including C-reactive protein and eGFR, in predicting periodontal disease: a longitudinal study. Int J Mol Sci 2024;26(2):741. doi:10.3390/ijms26020741.
35. Munagala KK, Nanda S, Chowdhary Z, Pathivada L, Vivekanandan G, Bodhi S. Severity of periodontal disease in chronic kidney disease patients: a hospital-based study. Cureus 2022;14(6):e25646. doi:10.7759/cureus.25646.
36. Ioannidou E, Swede H, Dongari-Bagtzoglou A. Periodontitis predicts elevated C-reactive protein levels in CKD. J Dent Res 2011;90(12):1411. doi:10.1177/0022034511423394.
37. Onabanjo OA, Nwhator SO, Arogundade FA. Association between periodontal inflamed surface area and systemic inflammatory biomarkers among pre-dialysis CKD patients. Niger Postgrad Med J 2023;30(4):299-304. doi:10.4103/npmj.npmj_124_23.
38. Esteves-Lima P, Reis S, Santirocchi-Júnior F, Abreu G, Costa O. Association between periodontitis and serum CRP levels. J Clin Exp Dent 2020;12(9):e838. doi:10.4317/jced.57041.
39. Lee H, Mun J. Relationship between C-reactive protein and periodontitis and systemic diseases. J Periodontol 2024;95(5):494-501. doi:10.1002/JPER.23-0008.
40. Chen H, Li J. Association between periodontitis and its treatment on mortality in ESRD: systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal 2023;29(3):e334. doi:10.4317/medoral.26307.
41. Abou-Bakr A, Hussein RR, Khalil E, Ahmed E. Frequency of periodontitis in ESRD hemodialysis patients in Egypt: multicenter study. BMC Oral Health 2022;22:1. doi:10.1186/s12903-021-02032-x.
42. Lv L, Gluckman TJ, Strum M, Rajpura J. Perceptions of hsCRP testing in atherosclerotic cardiovascular disease. Future Cardiol 2025;21(9):701. doi:10.1080/14796678.2025.2514349.
43. Craig R. Interactions between chronic renal disease and periodontal disease. Oral Dis 2007;14(1):1-7. doi:10.1111/j.1601-0825.2007.01430.x.
44. Jamal O, Aneni EC, Shaharyar S, et al. Cigarette smoking worsens systemic inflammation in metabolic syndrome. Diabetol Metab Syndr 2014;6:79. doi:10.1186/1758-5996-6-79.
45. Sułkowski L, Matyja A, Matyja M. Impact of dialysis duration on multidimensional health outcomes. J Clin Med 2024;14(2):376. doi:10.3390/jcm14020376.
46. Miki K, Kitamura M, Hatta K, et al. PISA associated with hs-CRP in septuagenarian Japanese adults. Sci Rep 2021;11:14436. doi:10.1038/s41598-021-93872-8.
47. Kumari R, Banerjee A, Verma A, Kumar A, Biswas N, Kumari P. Correlation of PISA with systemic inflammatory markers. Cureus 2024;16(6):e62389. doi:10.7759/cureus.62389.
48. D’Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005;84(3):269-73. doi:10.1177/154405910508400312.
49. Mance Kristan R, Jurgec S, Potocnik U, Marhl M, Gaspersic R. Association between PISA, inflammatory biomarkers, and mitochondrial DNA copy number. J Clin Med 2024;14(1):24. doi:10.3390/jcm14010024.
50. Sun J, Wang W, Li D, et al. Association between CRP and periodontitis in an obese population (NHANES 2009–2010). BMC Oral Health 2023;23:512. doi:10.1186/s12903-023-03189-3.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Sara Hamid Mohammed, Nada Tawfig Hashim, Salma Musa Adam Abduljalil, Randa Mohamed Ali Homyda, Muhammed Mustahsen Rahman , Bakri Gobara Gismalla

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

